Moreover, KDM2A contributes to metabolic rewiring of CSCs via regulation of PGC-1α and promotes stromal remodeling through activation of cancer-associated fibroblasts, further impairing immune and stromal surveillance in BC [293]. The gene discussed is KDM2A; the disease is cancer.